1. Home
  2. LGND vs NBTB Comparison

LGND vs NBTB Comparison

Compare LGND & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • NBTB
  • Stock Information
  • Founded
  • LGND 1987
  • NBTB 1856
  • Country
  • LGND United States
  • NBTB United States
  • Employees
  • LGND N/A
  • NBTB N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • NBTB Major Banks
  • Sector
  • LGND Health Care
  • NBTB Finance
  • Exchange
  • LGND Nasdaq
  • NBTB Nasdaq
  • Market Cap
  • LGND 2.0B
  • NBTB 2.3B
  • IPO Year
  • LGND 1992
  • NBTB N/A
  • Fundamental
  • Price
  • LGND $108.55
  • NBTB $42.36
  • Analyst Decision
  • LGND Strong Buy
  • NBTB Hold
  • Analyst Count
  • LGND 7
  • NBTB 3
  • Target Price
  • LGND $144.67
  • NBTB $54.67
  • AVG Volume (30 Days)
  • LGND 116.1K
  • NBTB 275.4K
  • Earning Date
  • LGND 05-08-2025
  • NBTB 04-24-2025
  • Dividend Yield
  • LGND N/A
  • NBTB 3.21%
  • EPS Growth
  • LGND N/A
  • NBTB 12.07
  • EPS
  • LGND N/A
  • NBTB 2.97
  • Revenue
  • LGND $167,133,000.00
  • NBTB $557,339,000.00
  • Revenue This Year
  • LGND $16.47
  • NBTB $25.56
  • Revenue Next Year
  • LGND $19.44
  • NBTB $12.40
  • P/E Ratio
  • LGND N/A
  • NBTB $14.26
  • Revenue Growth
  • LGND 27.28
  • NBTB 13.66
  • 52 Week Low
  • LGND $69.17
  • NBTB $34.47
  • 52 Week High
  • LGND $129.90
  • NBTB $52.44
  • Technical
  • Relative Strength Index (RSI)
  • LGND 53.94
  • NBTB 55.90
  • Support Level
  • LGND $101.24
  • NBTB $39.14
  • Resistance Level
  • LGND $111.39
  • NBTB $43.21
  • Average True Range (ATR)
  • LGND 5.67
  • NBTB 1.71
  • MACD
  • LGND 0.82
  • NBTB 0.48
  • Stochastic Oscillator
  • LGND 84.05
  • NBTB 85.59

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. NBT Bank is a full-service community bank offering a full range of retail and commercial banking products and trust and investment services. Loan products include consumer, home equity, mortgage, business banking, and commercial loans. Nearly half of its loan portfolio is in commercial loans. The bank serves individuals, corporations, and municipalities, and operates scores of locations throughout New York, Pennsylvania, Vermont, Massachusetts, New Hampshire, and Maine.

Share on Social Networks: